Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease

<div>ROC curves of TE, GPR, APRI, and FIB-4 for significant fibrosis assessment (a) and cirrhosis assessment (b) in CHB patients with NAFLD. TE: transient elastography; GPR: gamma-glutamyl transpeptidase-to-platelet ratio; APRI: aspartate aminotransferase- (AST-) to-platelet ratio index; FIB-4: fibrosis-4; AUC: area under the ROC curve; 95% CI: 95% confidence interval.</div>

Disease Markers

fig3

Figure 3

Figure 3: Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease 

Figure 3 | Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease 